Merck Subsidiary to Market BioServe Biotechnologies Products in India | GenomeWeb
NEW YORK (GenomeWeb News) — Merck Specialties, an Indian subsidiary of Merck, will market and distribute BioServe Biotechnologies’ DNA and RNA purification reagents and DNA sequencing, oligonucleotide synthesis, and molecular biology teaching kits.
 
BioServe said the companies plan to extend the deal throughout Asia later in 2007.
 
BioServe has bases in Hyderabad, India, and in Laurel, Md.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.